42 results
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
11 May 22
Cocrystal Pharma Reports First Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs and Milestones
8:30am
in the current challenging economic environment, given our clean capital structure and a cash balance we believe is sufficient to fund planned operations
8-K
EX-10.1
xl45s83zk q31
31 Jan 20
Entry into a Material Definitive Agreement
8:01am
8-K
EX-1.1
ccn2wpqqk72
27 Aug 20
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-10.1
xkhp2
4 Mar 20
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
5:09pm
8-K
EX-10.1
zwjgsei 9pj
13 Mar 20
Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market
4:44pm
8-K
EX-1.1
f3txrmnoc4b
5 May 21
Entry into a Material Definitive Agreement
5:02pm
8-K
EX-1.1
ebzvjrzalv
30 Oct 19
Entry into a Material Definitive Agreement
4:38pm
8-K
EX-1.1
t40n6yp7 8329isthgly
2 Jul 20
Entry into a Material Definitive Agreement
9:30am
8-K
EX-1.1
rrrf4
20 Jul 18
Entry into a Material Definitive Agreement
4:50pm
8-K
EX-10.1
b0m08w5nubz 42rmy1
18 Apr 13
Unregistered Sales of Equity Securities
12:00am